DaVita Inc
F:TRL

Watchlist Manager
DaVita Inc Logo
DaVita Inc
F:TRL
Watchlist
Price: 131.55 EUR 1.08% Market Closed
Market Cap: €11.5B

DaVita Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

DaVita Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
DaVita Inc
NYSE:DVA
Revenue
$13.6B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Revenue
$11.3B
CAGR 3-Years
6%
CAGR 5-Years
2%
CAGR 10-Years
4%
CVS Health Corp
NYSE:CVS
Revenue
$402.1B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
10%
Cigna Corp
NYSE:CI
Revenue
$274.9B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
22%
Laboratory Corporation of America Holdings
NYSE:LH
Revenue
$14B
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
5%
Guardant Health Inc
NASDAQ:GH
Revenue
$982m
CAGR 3-Years
30%
CAGR 5-Years
28%
CAGR 10-Years
N/A
No Stocks Found

DaVita Inc
Glance View

In the intricate network of healthcare services, DaVita Inc. stands as a pivotal player, focusing on the often-overlooked but critical field of kidney care. Rooted in its mission to improve patients' quality of life by innovating kidney care therapies, DaVita has cultivated a robust operation primarily revolving around dialysis services. Chronic Kidney Disease (CKD) and kidney failure are rising global health concerns, necessitating regular dialysis treatments for affected individuals. DaVita serves this need through a network of dialysis centers, offering both in-center and at-home dialysis options. By prioritizing patient comfort and convenience alongside medical efficiency, DaVita has positioned itself as a go-to choice for those requiring ongoing renal care, effectively making the process as seamless as possible for patients. The business model of DaVita hinges on its ability to deliver consistent, high-quality care while managing costs—a balance crucial to success in the healthcare industry. Revenue flows in from both governmental programs such as Medicare and private health insurers, which fund the dialysis treatments for insured patients. DaVita's strategic strength lies in its operational scale, with a vast number of outpatient dialysis centers across the U.S. and internationally. This extensive reach not only strengthens its market position but also provides a wealth of data and feedback, fueling further innovation and efficiency improvements. By leveraging this extensive network, DaVita continues to tap into the growing demand for accessible, comprehensive kidney care services, reinforcing its commitment to patient-centered healthcare delivery while sustaining its financial growth.

TRL Intrinsic Value
232.95 EUR
Undervaluation 44%
Intrinsic Value
Price €131.55

See Also

What is DaVita Inc's Revenue?
Revenue
13.6B USD

Based on the financial report for Dec 31, 2025, DaVita Inc's Revenue amounts to 13.6B USD.

What is DaVita Inc's Revenue growth rate?
Revenue CAGR 10Y
0%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for DaVita Inc have been 6% over the past three years , 3% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett